<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="27769" end="27774" sStart="27490" offset="279" sid="r7.1.use.v.0594" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="Proteolytic fragments separated by SDS-PAGE were transferred to ProBlott PVDF membranes (Applied Biosystems, Inc.) as described by LeGendre et al [ 38 ] . Coomassie-stained protein bands were then subjected to sequence analysis using either a Model 491 or Model 470A gas phase sequencer equipped with a Model 120A on-line phenylthiohydantoin analyzer (Applied Biosystems, Inc)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="24217" end="24222" sStart="null" offset="459" sid="r7.1.use.v.0578" wn="1" wnkey="use%2:34:01::" annotator="jeneale" text="A fragment containing the PPT1 ORF was excised from the pBII-PPT1 using Eco RI and Xho I restriction enzymes and was subcloned downstream of the GST coding region into the Eco RI and Sal I sites of the bacterial expression vector pET-21a GST [ 37 ] . To construct the pET-GST-PPT1 (1-504) plasmid a 453 bp fragment was amplified from pET-GST-PPT1 by PCR using a 3' primer containing a Xho I restriction site and a stop codon designed to truncate the PPT1 gene product at Met504 (5'-gatcctcgagTTAcattggttttatatctggg) and a 5' primer (5'-gtaatgcatggtggttta) encompassing the Nsi I restriction site of PPT1 . The PCR product was cloned into the Nsi I and Xho I restriction sites of pET-GST-PPT1 and sequenced." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="12468" end="12473" sStart="null" offset="72" sid="r7.1.use.v.0419" wn="1" wnkey="use%2:34:01::" annotator="brubin" text="Direct fluorescence from EGFP and indirect immunofluorescence using the amplification protocol with anti-EGFP antibody were compared." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="31468" end="31479" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="veweser" text="The total protein was extracted from approximately 10 7cells by vortexing with glass beads, then resolved by SDS-PAGE on 12% gel, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose at 55V in (25 mM Tris, 250 mM glycine, 0.1% SDS, and 20% methanol) for 1 hr at room temperature." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="31468" end="31479" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="jeneale" text="The total protein was extracted from approximately 10 7cells by vortexing with glass beads, then resolved by SDS-PAGE on 12% gel, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose at 55V in (25 mM Tris, 250 mM glycine, 0.1% SDS, and 20% methanol) for 1 hr at room temperature." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="27549" end="27560" sStart="null" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" annotator="carichter" text="Proteolytic fragments separated by SDS-PAGE were &lt;b&gt;transferred&lt;/b&gt; to ProBlott PVDF membranes (Applied Biosystems, Inc.) as described by LeGendre et al [ 38 ] . Coomassie-stained protein bands were then subjected to sequence analysis using either a Model 491 or Model 470A gas phase sequencer equipped with a Model 120A on-line phenylthiohydantoin analyzer (Applied Biosystems, Inc)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="34224" end="34235" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="The gel was rinsed with diethylpyrocarbonate-treated H 2 O and the RNA was &lt;b&gt;transferred&lt;/b&gt; to a Hybond N+ membrane (Amersham Biosciences) by capillary transfer in alkaline solution (0." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="31468" end="31479" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" annotator="carichter" text="The total protein was extracted from approximately 10 7cells by vortexing with glass beads, then resolved by SDS-PAGE on 12% gel, and &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose at 55V in (25 mM Tris, 250 mM glycine, 0.1% SDS, and 20% methanol) for 1 hr at room temperature." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="13728" end="13735" sStart="null" offset="148" sid="r8.suggest.v.0757" wn="3" wnkey="suggest%2:32:02::" annotator="veweser" text="In the case of mammalian PP5, results from lipid stimulation and binding, limited proteolysis and truncation studies taken together suggest the TPR domain and the C terminus inhibit PP5 activity in a coordinated manner and that lipid binding to the TPR domain activates the enzyme in vitro [ 18 19 20 ] . In the present study we used assay conditions for Ppt1p identical to those in which PP5 was shown to be activated by removal of the TPR or C-terminal regions [ 19 ] . Under these conditions Ppt1p is also stimulated by lipids toward 32P-MBP, and activating lipids slow TPR domain proteolysis." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="21260" end="21270" sStart="null" offset="297" sid="r8.suggest.v.0916" wn="3" wnkey="suggest%2:32:02::" annotator="cgozo" text="Ppt1p shares several biochemical properties with PP5 and other homologs, including a similar domain structure and stimulation by lipid in vitro . Unlike PP5, Ppt1p is not fully activated by removal of the TPR domain or by removal of 9 C-terminal residues, suggesting that these regions may not play an autoinhibitory role in Ppt1p." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="37060" end="37064" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" annotator="cgozo" text="All authors &lt;b&gt;read&lt;/b&gt; and approved the final manuscript." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20893" end="20898" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="veweser" text="Studies of PP5 and its homologs in cultured cells and various organisms also suggest it may play a role in development [ 5 6 ] or during &lt;b&gt;rapid&lt;/b&gt; cell growth [ 2 7 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="2147483647" wnkey="null" annotator="tofox" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20893" end="20898" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="tofox" text="Studies of PP5 and its homologs in cultured cells and various organisms also suggest it may play a role in development [ 5 6 ] or during &lt;b&gt;rapid&lt;/b&gt; cell growth [ 2 7 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="elstickles" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" annotator="comcgeetubb" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="20280" end="20285" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" annotator="carichter" text="Ppt1p levels are highest during periods of &lt;b&gt;rapid&lt;/b&gt; growth and drop off when growth slows (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="16597" end="16601" sStart="null" offset="370" sid="r7.poor.j.0826" wn="5" wnkey="poor%5:00:00:insufficient:00" annotator="jeneale" text="Like PP5, the control activity of Ppt1p is low toward the commonly used artificial substrates such as 32P-casein and 32P-MBP compared to other PPP enzymes [ 18 ] . Thus, it is not clear whether the selective lipid stimulation of Ppt1p toward 32P-MBP reflects a substrate-directed effect, or whether 32P-casein is simply a poor substrate for Ppt1p." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="11060" end="11066" sStart="null" offset="65" sid="r9.level.n.0576" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="Northern analysis showed that the PPT1 mRNA levels also increased in early log phase and decreased as the cell division decreased upon entering the stationary phase (Fig." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="3065" end="3070" sStart="null" offset="119" sid="r9.level.n.0396" wn="2" wnkey="level%1:26:01::" annotator="brubin" text="In this report we have characterized the activity of recombinant Ppt1p, analyzed its expression at the level of protein and mRNA, and localized Ppt1p in yeast." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-4-3.anc" start="1167" end="1172" sStart="null" offset="0" sid="null" wn="9" wnkey="know%2:31:11::" annotator="elstickles" text="Protein phosphatase 5 has been implicated in the control of cell proliferation, in hormonal signal transduction, and in hsp90 chaperone function [ 3 11 12 13 14 15 16 17 ] . However little is &lt;b&gt;known&lt;/b&gt; about the regulation of PP5 or its specific role in these pathways, and only one physiological substrate for PP5 has been identified to date, the apoptosis signaling kinase ASK 1 [ 13 ] . PP5 can be activated by lipid in vitro , and removal of the TPR domain or the C terminus generates an active, lipid insensitive form of the enzyme [ 18 19 20 21 ] . PP5 phosphatase activity is also altered by hCRY2 and a fragment of hsp90 in vitro [ 21 22 ] . These findings suggest that PP5 may be autoinhibited and that the binding of protein partners or lipids to the TPR domain could potentially control PP5 activity in cells, however no reports have yet documented how PP5 is regulated in vivo . The activity of PP5 homologs from cauliflower, T. brucei and P. falciparum is stimulated by polyunsaturated fatty acids in vitro [ 7 8 9 10 ] and removal of the TPR domain from P. falciparum PP5 increases activity to the same extent as lipid treatment [ 8 9 ] . This suggests that the TPR domain plays a similar inhibitory role for all PP5 homologs." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2121-4-3.anc" start="1167" end="1172" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" annotator="carichter" text="Protein phosphatase 5 has been implicated in the control of cell proliferation, in hormonal signal transduction, and in hsp90 chaperone function [ 3 11 12 13 14 15 16 17 ] . However little is &lt;b&gt;known&lt;/b&gt; about the regulation of PP5 or its specific role in these pathways, and only one physiological substrate for PP5 has been identified to date, the apoptosis signaling kinase ASK 1 [ 13 ] . PP5 can be activated by lipid in vitro , and removal of the TPR domain or the C terminus generates an active, lipid insensitive form of the enzyme [ 18 19 20 21 ] . PP5 phosphatase activity is also altered by hCRY2 and a fragment of hsp90 in vitro [ 21 22 ] . These findings suggest that PP5 may be autoinhibited and that the binding of protein partners or lipids to the TPR domain could potentially control PP5 activity in cells, however no reports have yet documented how PP5 is regulated in vivo . The activity of PP5 homologs from cauliflower, T. brucei and P. falciparum is stimulated by polyunsaturated fatty acids in vitro [ 7 8 9 10 ] and removal of the TPR domain from P. falciparum PP5 increases activity to the same extent as lipid treatment [ 8 9 ] . This suggests that the TPR domain plays a similar inhibitory role for all PP5 homologs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="8509" end="8513" sStart="null" offset="119" sid="r9.fold.v.0415" wn="2147483645" wnkey="null" annotator="cgozo" text="However, removal of the TPR domain only modestly increases Ppt1p activity, in contrast to the 5-25 fold elevation reported after TPR removal from PP5 [ 19 20 ] . Although we cannot rule out the possibility that proteolyzed Ppt1p is unresponsive to lipid because it is unstable, the observations that the catalytic fragment remains undegraded and control activity is not decreased argue against this possibility." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="4356" end="4360" sStart="null" offset="252" sid="r9.fold.v.0359" wn="2147483645" wnkey="null" annotator="cgozo" text="In the case of pNPP hydrolysis, others have reported both saturated and unsaturated fatty acyl coenzyme A esters stimulate PP5 activity, with concentrations required for half-maximal stimulation approximately 10-fold lower than those of their corresponding free fatty acids [ 21 ] . We therefore tested whether a saturated fatty acyl coenzyme A ester could also stimulate Ppt1p." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="17977" end="17981" sStart="null" offset="265" sid="r9.fold.v.0866" wn="" wnkey="null" annotator="anfahmy" text="Others have proposed that fatty acyl coenzyme A esters are potential physiologic regulators of PP5, since these compounds stimulate pNPP hydrolysis by PP5 in vitro at physiologically relevant concentrations and are approximately 10-fold more potent than their free fatty acid counterparts [ 21 ] . Although we confirmed this observation using PP5 and pNPP (data not shown), in our hands similar levels of AA and arachidoyl coenzyme A were required for half-maximal stimulation of 32P-MBP dephosphorylation in the case of both Ppt1p and PP5." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="17344" end="17348" sStart="null" offset="276" sid="r7.1.face.n.0342" wn="6" wnkey="face%1:15:00::" annotator="jeneale" text="Using the program Modeller [ 26 ] , a homology model of the catalytic domain of Ppt1p was built based on three PP1 structures - PDB http://www.pdb.org [ 27 ] codes 1FJM [ 28 ] , 1IT6 [ 29 ] and 1JK7 [ 30 ] . This model shows that the catalytic face of Ppt1p is generally less acidic than that of PP1c ? and does not indicate the presence of other acidic residues that could act in the same fashion as those on PP1c ?." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="16719" end="16723" sStart="null" offset="96" sid="r7.1.face.n.0224" wn="6" wnkey="face%1:15:00::" annotator="cgozo" text="Egloff and colleagues identified seven acidic surface residues on the catalytic face of PP1c ? that are replaced by neutral or basic residues in PP2A [ 25 ] . They suggest the presence of these acidic residues in PP1c ? may explain why casein is a good substrate for PP2A, but not for PP1." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="16241" end="16248" sStart="null" offset="14" sid="r10.control.n.0994" wn="1" wnkey="control%1:07:00::" annotator="anfahmy" text="Like PP5, the control activity of Ppt1p is low toward the commonly used artificial substrates such as 32P-casein and 32P-MBP compared to other PPP enzymes [ 18 ] . Thus, it is not clear whether the selective lipid stimulation of Ppt1p toward 32P-MBP reflects a substrate-directed effect, or whether 32P-casein is simply a poor substrate for Ppt1p." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="22166" end="22172" sStart="null" offset="214" sid="r10.common.j.0836" wn="3" wnkey="common%5:00:00:shared:00" annotator="brubin" text="In addition a recent report has shown that Ppt1p is co-purified with Hsp82p and Hsc82p, the S. cerevisiae homologs of hsp90 [ 36 ] , indicating that Ppt1p and PP5 have at least one common protein partner and suggesting that, like PP5, Ppt1p functions in chaperone complexes." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2121-4-3.anc" start="33614" end="33619" sStart="null" offset="0" sid="null" wn="1" wnkey="coloring%1:07:00::" annotator="brubin" text="The specimens were examined with a BX60 fluorescence microscope (Olympus) and &lt;b&gt;images&lt;/b&gt; captured using a RT220 &lt;b&gt;color&lt;/b&gt; digital camera (Diagnostic Instruments, Inc.)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="7240" end="7248" sStart="null" offset="121" sid="r9.appear.v.0280" wn="2" wnkey="appear%2:30:00::" annotator="brubin" text="A 20 kDa fragment was observed at early times, but a series of four fragments ranging from 14-16 kDa appeared between 10 and 30 min as the amount of the 20 kDa fragment decreased." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2121-4-3.anc" start="6073" end="6080" sStart="null" offset="263" sid="r11.absence.n.0358" wn="1" wnkey="absence%1:26:00::" annotator="vebatchelder" text="Removal of the TPR domain of PP5 by limited proteolysis increases enzyme activity and the TPR domain binds lipid [ 7 8 9 19 20 ] . Using conditions similar to those employed with PP5, digestion of Ppt1p with trypsin in the absence of lipid produced a 44 kDa catalytic fragment that was stable for at least 30 min and a 20 kDa fragment that was degraded within 30 min (Fig." />
  </sentences>
</list>